Lundbeck Antipsychotic Sertindole Suspended From U.K. Market

Lundbeck's antipsychotic sertindole has been suspended from the U.K. market "due to concerns about reports of cardiac arrhythmias and sudden cardiac arrest," the U.K. Committee for the Safety of Medicines told prescribers Dec. 2.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet